Nakamoto Inc Revenue Growth Rates (NAKA), Current and Historic Growth - CSIMarket
CSIMarket
 


Nakamoto Inc   (NASDAQ: NAKA)
 

NAKA's Revenue Growth by Quarter and Year

Nakamoto Inc 's Revenue results by quarter and year




NAKA Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 25.45
1st Quarter March 2.68
FY 28.13





NAKA Revenue second quarter 2026 Y/Y Growth Comment
Nakamoto Inc achieved in the second quarter 2026, above Company average Revenue surge of 6107.56% year on year, to $ 25.45 millions.

Looking into second quarter 2026 results within Medical Equipment & Supplies industry 148 other companies have achieved higher Revenue growth. While Nakamoto Inc ' s Revenue doubling of 6107.56% ranks overall at the positon no. 3122 in the second quarter 2026.




NAKA Revenue ( Y/Y Growth %) 2026
2025 2024 2023
4th Quarter December - -26.67 % -21.05 % -
3rd Quarter September - -40 % -25.29 % -
2nd Quarter June 6107.56 % -35.94 % -34.69 % -
1st Quarter March 362.07 % -30.12 % -28.45 % -
FY   - -33.09 % -27.85 % -

Financial Statements
Nakamoto Inc 's second quarter 2026 Revenue $ 25.45 millions NAKA's Income Statement
Nakamoto Inc 's second quarter 2025 Revenue $ 0.41 millions Quarterly NAKA's Income Statement


NAKA Revenue (Quarter on Quarter Growth %)

2026
2025 2024 2023
4th Quarter December - 12.82 % -7.69 % -12.64 %
3rd Quarter September - -4.88 % 1.56 % -11.22 %
2nd Quarter June 849.66 % -29.31 % -22.89 % -15.52 %
1st Quarter March 509.09 % -3.33 % 9.21 % -
FY (Year on Year)   - -33.09 % -27.85 % -




Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #149
Healthcare Sector #422
Overall #3122

Revenue Y/Y Growth Statistics
High Average Low
1192.99 % 188.61 % -33.04 %
(Jun 30 2026)   (Dec 31 2025)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #149
Healthcare Sector #422
Overall #3122
Revenue Y/Y Growth Statistics
High Average Low
1192.99 % 188.61 % -33.04 %
(Jun 30 2026)   (Dec 31 2025)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Nakamoto Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
850.37 % 97.67 % -29.52 %
(Jun 30 2026)  


NAKA's II. Quarter Q/Q Revenue Comment
Nakamoto Inc achieved in the II. Quarter 2026 above company average sequential Revenue doubling of 849.66%, to $ 25.45 millions, from $2.68 millions in the first quarter.
NAKA is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry Nakamoto Inc achieved highest sequential Revenue growth. While Nakamoto Inc 's Revenue growth quarter on quarter, overall rank is 34.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #0
Healthcare Sector #12
Overall #34
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #0
Healthcare Sector #12
Overall #34
Revenue Q/Q Growth Statistics
High Average Low
850.37 % 97.67 % -29.52 %
(Jun 30 2026)  


NAKA's II. Quarter Q/Q Revenue Comment
Nakamoto Inc achieved in the II. Quarter 2026 above company average sequential Revenue doubling of 849.66%, to $ 25.45 millions, from $2.68 millions in the first quarter.
NAKA is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry Nakamoto Inc achieved highest sequential Revenue growth. While Nakamoto Inc 's Revenue growth quarter on quarter, overall rank is 34.


Nakamoto Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)
12 Months Ending
(Mar 31 2026)
12 Months Ending
(Dec 31 2025)
12 Months Ending
(Sep 30 2025)
12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 28.96 $ 3.92 $ 1.82 $ 1.98 $ 2.24
Y / Y Revenue Growth (TTM) 1192.99 % 58.66 % -33.04 % -31.13 % -27.67 %
Year on Year Revenue Growth Overall Ranking # 3429 # 2896 # 0 # 0 # 0
Seqeuential Revenue Change (TTM) 638.89 % 115.21 % -8.03 % -11.59 % -9.33 %
Seq. Revenue Growth (TTM) Overall Ranking # 3122 # 2591 # 0 # 2534 # 0


Cumulative Revenue growth Comment
With 1192.99% annual Revenue growth, Nakamoto Inc would report a record annual Revenue surge if the fiscal year would end on Jun 30 2026.

In the Healthcare sector 465 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2896 to 3429.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 149
Healthcare Sector # 466
Overall # 3429

Revenue TTM Y/Y Growth Statistics
High Average Low
1192.99 %
188.61 %
-33.04 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 149
Sector # 422
S&P 500 # 3122
Cumulative Revenue growth Comment
With 1192.99% annual Revenue growth, Nakamoto Inc would report a record annual Revenue surge if the fiscal year would end on Jun 30 2026.

In the Healthcare sector 465 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2896 to 3429.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 149
Healthcare Sector # 466
Overall # 3429

Revenue TTM Y/Y Growth Statistics
High Average Low
1192.99 %
188.61 %
-33.04 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 149
Sector # 422
S&P 500 # 3122




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
NAKA's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue surge for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Meiragtx Holdings Plc8,608.59%$ 8,608.588 millions
Nakamoto Inc 6,129.94%$ 6,129.943 millions
Connect Biopharma Holdings Limited5,666.67%$ 5,666.667 millions
Hcw Biologics Inc 3,828.21%$ 3,828.214 millions
Protagonist Therapeutics inc 3,749.17%$ 3,749.171 millions


About Nakamoto Inc Revenue Growth Rates (NAKA), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Nakamoto Inc (CIK 1946573).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001493152-26-037603
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Nakamoto Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.